Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”. // Annals of Thoracic Surgery Short Reports. – URL: https://www.sciencedirect.com/science/article/pii/S1665268126000360?dgcid=rss_sd_all
Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”. Annals of Thoracic Surgery Short Reports. https://www.sciencedirect.com/science/article/pii/S1665268126000360?dgcid=rss_sd_all
“Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”.” Annals of Thoracic Surgery Short Reports.
@article{article3456,
title = {Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”},
journal = {Annals of Thoracic Surgery Short Reports},
url = {https://www.sciencedirect.com/science/article/pii/S1665268126000360?dgcid=rss_sd_all}
}
Publication date: January–June 2027 Source: Annals of Hepatology, Volume 32, Issue 1 Author(s): Marie Louise N. Therkelsen, Liv Eline Hetland, Mikkel Parsberg Werge, Mira Thing, Elias Badal Rashu, Puria Nabilou, Nina Kimer, Anders...